Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of aficamten (CK-3773274) in adults with symptomatic hypertrophic cardiomyopathy and left ventricular outflow tract obstruction

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05186818
Study type Interventional
Source Cytokinetics
Contact Cytokinetics MD
Phone 650-624-2929
Email [email protected]
Status Not yet recruiting
Phase Phase 3
Start date January 2022
Completion date September 2023